Gynecological endocrinology in age aspect: problems and decisions

Russian scientific and practical congress

7 – 9 November, 2019  2019-11-07 09:00:00 2019-11-09 18:00:00 Europe/Moscow Gynecological endocrinology in age aspect: problems and decisions National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Health of Russia, Moscow Congress operator LLC "MEDI Expo" expo@mediexpo.ru

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Health of Russia, Moscow read more

Leaders of conference

G.T. Sukhikh
Professor, Academician of RAS Director of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Health of Russia Head of the Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University
  G.E. Chernukha
Head of the Department of Gynecological Endocrinology, Professor

Dear colleagues!

We invite you to take part in the Russian Scientific and Practical Congress "Gynecological endocrinology in the age aspect: problems and solutions"

During the congress, the following key issues of women's health for various age periods of women from menarche to menopause will be considered:

  • Molecular genetic, epigenetic and immunological foundations of reproductive system dysfunction, a new view on tissue and molecular genetic signaling pathways of folliculogenesis, the possibility of new approaches to the treatment of ovarian, stump and PCOS tumors taking into account the laws of mechanotransduction
  • Determining the stages of aging of the female reproductive system (STRAW + 10 criteria), as the basis of modern gynecological practice
  • Genomic and non-genomic effects of endo- and exogenous sex hormones
  • Cell technology in gynecology
  • Various forms of amenorrhea - organic and functional disorders at various levels of reproductive disorders
  • Polycystic ovary syndrome: maintaining reproductive function and health (inhibitory aromatases, their place in overcoming anovulatory infertility, the role of insulin sensitizers in the treatment of PCOS)
  • The use of mass spectrometry in the diagnosis of hyper- and androgen-deficient conditions in gynecology and their correction
  • Fat metabolism, metabolic syndrome and reproductive function
  • Functional hypothalamic amenorrhea from the perspective of the theory of metabolic adaptation, paradigm shift in treatment
  • Thin endometrium - what's new? Modern therapeutic approaches
  • Uterine bleeding in the light of the modern possibilities of drug therapy and recent recommendations
  • Therapeutic aspects of hormonal contraception
  • "Niche" of GnRH agonists / antagonists and sex hormones in gynecological practice
  • Oncology of reproductive disorders from molecular biology to oncofertility
  • Combined uterine pathology (uterine fibroids, adenomyosis, endometrial hyperplasia): focus on uterine preservation
  • Preserving the health of mature women: 21st century strategies
  • Innovation, Evidence, and Individualization: Moving into the Future of Menopause Management
  • Management of Transitional and Post-Menopausal Women: A Review of Recent Recommendations from Leading International Menopause Organizations
  • Perimenopause Contraception
  • Fertility after 40 years: what is real and what is not?
  • New about the etiology of hot flushes: KNDy neurons, the signal pathway of receptor 3 neurokinin. Treatment of vasomotor symptoms with neurokinin antagonists
  • The theory of “eu-estrogenism” and the window of therapeutic possibilities of MHT: what is the contradiction?
  • Perimenopause as a “state of neurological transition": the possibility of preventing neurodegenerative diseases
  • Perimenopausal Depression: Recommendations for Diagnosis and Treatment (2018)
  • Gender differences in risk factors, course and prevention of cardiovascular diseases in women: the possibility of MHT in the light of recent evidence-based studies
  • Assessment of obesity in postmenopausal women: what is the main problem?
  • MHT and oncological diseases: reality and myths
  • Androgens and their role in postmenopausal women: what we know today. Facts for and against?
  • Who needs a genetic examination for breast cancer?
  • Systemic MHT after prophylactic operations in carriers of BRCA gene mutations
  • Efficiency and safety of alternative therapy for menopausal disorders (SERM, TSEC, SSRIs, SSRIs, PPG peptides, phytoestrogens, etc.)
  • Genitourinar menopause syndrome. Consensus, new therapeutic approaches
  • Postmenopausal osteoporosis (diagnosis and therapeutic approaches)
  • The role of hormones and metabolic disorders in the genesis of “age-related” osteoarthritis.

The head of the Congress:

Head of the Department of Gynecological Endocrinology
Professor
G.E. Chernukha

Exhibition exposition

During the Congress an exhibition exposition will work